Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines.
Mueller
Henrik
H
Pharmaceutical Institute, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany.
Kassack
Matthias U
MU
Wiese
Michael
M
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000032:analysis*; D001681:Biological Assay / Q000379:methods*; D002470:Cell Survival; D002945:Cisplatin / Q000032:analysis / Q000494:pharmacology; D000077143:Docetaxel; D004317:Doxorubicin / Q000032:analysis / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor; D005260:Female; D005452:Fluoresceins / Q000032:analysis*; D006801:Humans; D025341:Principal Component Analysis / Q000379:methods*; D043823:Taxoids / Q000032:analysis / Q000494:pharmacology; D013778:Tetrazolium Salts / Q000032:analysis*; D013844:Thiazoles / Q000032:analysis*; D014407:Tumor Cells, Cultured; D014747:Vinblastine / Q000032:analysis / Q000494:pharmacology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D005452:Fluoresceins; D043823:Taxoids; D013778:Tetrazolium Salts; D013844:Thiazoles; D000077143:Docetaxel; D014747:Vinblastine; D004317:Doxorubicin; D000255:Adenosine Triphosphate; C022616:thiazolyl blue; D002945:Cisplatin; C007740:fluorexon